$501 Million is the total value of SECTOR GAMMA AS's 29 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 14.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MRK | Buy | MERCK & CO INC | $61,050,000 | +72.4% | 812,814 | +78.5% | 12.18% | +94.1% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $26,150,000 | +40.1% | 602,682 | +38.1% | 5.22% | +57.9% |
CAH | Buy | CARDINAL HEALTH INC | $25,898,000 | +23.0% | 523,606 | +41.9% | 5.17% | +38.5% |
BIIB | Buy | BIOGEN INC | $23,578,000 | -6.8% | 83,319 | +14.1% | 4.70% | +5.0% |
INCY | Buy | INCYTE CORP | $20,822,000 | -12.9% | 302,739 | +6.5% | 4.15% | -1.9% |
BAX | Buy | BAXTER INTL INC | $19,096,000 | +23.1% | 237,429 | +23.2% | 3.81% | +38.6% |
NUVA | Buy | NUVASIVE INC | $17,861,000 | -10.3% | 298,426 | +1.6% | 3.56% | +1.0% |
QGEN | Buy | QIAGEN NV | $17,066,000 | +120.4% | 330,220 | +106.3% | 3.40% | +148.1% |
XRAY | New | DENTSPLY SIRONA INC | $14,590,000 | – | 251,330 | +100.0% | 2.91% | – |
ELAN | Buy | ELANCO ANIMAL HEALTH INC | $13,066,000 | -5.0% | 409,731 | +3.3% | 2.61% | +7.0% |
IONS | Buy | IONIS PHARMACEUTICALS INC | $8,850,000 | -15.8% | 263,870 | +0.1% | 1.76% | -5.2% |
UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $6,959,000 | +62.7% | 50,295 | +72.2% | 1.39% | +83.1% |
RIGL | Buy | RIGEL PHARMACEUTICALS INC | $6,435,000 | -13.1% | 1,772,730 | +3.9% | 1.28% | -2.1% |
PDCO | Buy | PATTERSON COS INC | $5,140,000 | +19.3% | 170,547 | +20.3% | 1.02% | +34.3% |
SAGE | Buy | SAGE THERAPEUTICS INC | $4,908,000 | -4.8% | 110,767 | +22.1% | 0.98% | +7.2% |
MRTX | New | MIRATI THERAPEUTICS INC | $4,600,000 | – | 26,000 | +100.0% | 0.92% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-10-29
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
PERKINELMER INC | 33 | Q2 2021 | 6.3% |
BIOGEN INC | 30 | Q3 2023 | 7.6% |
ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-08 |
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-06 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.